In the present study, we aimed to investigate the potential involvement of CD74 and D-DT and their receptors in COVID-19 patients with different disease severity, by employing an in silico analysis of a publicly available transcriptomic dataset and by measuring their serum levels by ELISA. The gene discussed is CD74; the disease is COVID-19.